Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis?
Saab
Georges
G
Abu-Alfa
Ali
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D005355:Fibrosis; D019786:Gadolinium DTPA / Q000009:adverse effects*; D005919:Glomerular Filtration Rate; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D008297:Male; D008536:Meglumine / Q000009:adverse effects / Q000031:analogs & derivatives; D008875:Middle Aged; D009942:Organometallic Compounds / Q000009:adverse effects; D051437:Renal Insufficiency / Q000150:complications*; D012307:Risk Factors; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000139:chemically induced*
D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine; C064925:gadodiamide; D019786:Gadolinium DTPA